SCHEMBL30359288

SCHEMBL30359288

COCOc1c(B2OC(C)(C)C(C)(C)O2)ccc(Cl)c1F

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.36
LPL P06858 1/20 0.32
LIPG Q9Y5X9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30359287 1.00 EGFR (0.36) EGFRLPLLIPG
SCHEMBL21410690 1.00 EGFR (0.36) EGFRLPLLIPG
SCHEMBL16047825 0.84 EGFR (0.39) EGFRLPLLIPG
SCHEMBL31265045 0.84 EGFR (0.39) EGFRLPLLIPG
SCHEMBL31302110 0.84 EGFR (0.36) EGFR
SCHEMBL4733734 0.83 EGFR (0.31) EGFR
SCHEMBL30796761 0.78 JAK2 (0.37) EGFRLPLLIPG
SCHEMBL26598153 0.78 EGFR (0.35) EGFRLPLLIPG
SCHEMBL1477534 0.77 LPL (0.42) EGFRLPLLIPG
SCHEMBL31183208 0.77 LPL (0.42) EGFRLPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436665-A1 HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-10-02 EP disclosed
WO-2023092149-A1 HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-05-25 WO disclosed